Good Documentation Practice (GDP) in Pharmaceuticals: Definition, Principles, 10 Cs, Regulatory Requirements, Key Components & FAQs

Introduction and Outcome

Good Documentation Practice (GDP) plays a critical role in the pharmaceutical industry because documentation is the most valuable asset of any regulated organisation. No matter how well a process is designed—from route selection and development to manufacturing and distribution—if an activity is not documented, it is considered not done.

GDP ensures the quality, safety, efficacy, traceability, and compliance of pharmaceutical products. It is also a core pillar of GLP, GMP, and GCP systems.
In this article, you will learn:

• The definition and principles of GDP
• The 10 Cs of documentation
• Regulatory requirements
• Key components and best practices
• Department-wise GDP implementation
• Do’s and Don’ts, examples, and FAQs

Good Documentation Practice (GDP): Definition

Good Documentation Practices (GDP) define the best practices for creating, reviewing, approving, maintaining, and archiving paper and electronic documents in regulated environments.

GDP applies to all critical pharmaceutical documents, including:

• SOPs and STPs
• Analytical method validation and technology transfer documents
• Raw data, laboratory notebooks, and batch records
• Deviations (OOS, OOT), investigations, and CAPA reports
• Calibration and maintenance records
• Training records
• Regulatory submissions (DMF, deficiency responses)

Principles of Good Documentation Practices

The principles of GDP focus on ensuring that documentation is:

• Accurate and clear
• Timely and traceable
• Consistent and legible
• Authorised and version-controlled
• Secure and retained appropriately
• Reviewed, validated, and risk-based
• Continuously improved through root cause analysis

10 Cs of Good Documentation Practices

The 10 Cs define effective document writing:

1. Clear – Simple and precise explanations
2. Concise – No unnecessary words
3. Correct – Free from grammatical and factual errors
4. Coherent – Logical and structured flow
5. Complete – All required information included
6. Creative – Expert-driven explanations where needed
7. Considerate – Easy to read with headings and bullets
8. Concrete – Specific details (dates, numbers, quantities)
9. Courteous – Professional tone, avoid commands
10. Credible – Fact-based, not opinion-based

Regulatory Requirements for GDP

GDP compliance is a legal and regulatory requirement in the pharmaceutical industry. Regulatory bodies such as the FDA, EMA, WHO, and ICH mandate strict documentation standards.

GDP is enforced through:

• 21 CFR Parts 210, 211, 58, and 11
• EU GMP Annexes
• WHO GMP guidelines

Failure to comply may lead to 483 observations, warning letters, recalls, or regulatory bans.

4 Key Components of Good Documentation Practices

1. Document Hierarchy and Organisation

A structured hierarchy improves accessibility, consistency, and audit readiness.

2. Document Control and Versioning

Ensures only current, approved documents are in use and older versions are archived.

3. Data Integrity and Validation

Maintains data accuracy, completeness, and reliability throughout its lifecycle.

4. Document Review and Approval

Formal QA review and approval ensure regulatory compliance and quality assurance.

5 Best Practices for Document Creation and Management

1. Define clear objectives and purpose
2. Standardise templates and formatting
3. Implement efficient review and approval workflows
4. Ensure document security and confidentiality
5. Maintain accuracy and completeness

GDP Across Pharmaceutical Departments

Manufacturing

• Batch manufacturing records
• Equipment calibration and maintenance logs
• Environmental monitoring records

Quality Control (QC) and Quality Assurance (QA)

• Test methods, results, and investigations
• OOS/OOT documentation
• Equipment qualification and validation records

Analytical & Chemical R&D

• Experimental protocols and observations
• Research findings and conclusions
• Intellectual property documentation

Training, Compliance, and GDP

• Regular GDP training is mandatory
• Training records must be documented
• Employees must understand the regulatory impact of documentation

Documenting Changes, Deviations, and Investigations

GDP ensures:

• Proper change control documentation
• Transparent deviation and incident reporting
• Effective communication to stakeholders

Role of GDP in Audits and Inspections

Effective GDP:

• Enables quick document retrieval
• Reduces audit observations
• Supports CAPA implementation and continuous improvement

GDP, Electronic Documentation, and Data Integrity

• SOPs must govern electronic documentation
• Use validated EDMS, LIMS, and ELNs
• Ensure audit trails, access control, and data security
• Comply with 21 CFR Part 11

GDP in Record Retention and Archiving

• Defined retention timelines
• Secure and controlled storage
• Easy retrieval for audits and inspections
• Controlled destruction after the retention period

Do’s and Don’ts of Good Documentation Practices

Do’s

• Write clearly and concisely
• Use approved templates
• Record data in real time
• Maintain version control
• Sign, date, and review documents

Don’ts

• Do not overwrite or erase data
• Do not leave blanks (use “N/A”)
• Do not backdate entries
• Do not use unapproved templates
• Do not skip reviews or approvals

3 Examples of GDP in Quality Control

1. Accurate Record Keeping – Legible, traceable, and secure QC records
2. SOP Compliance – Approved and trained procedures
3. Audit Trails – Full traceability of changes and results

Advantages of Good Documentation Practices

• Ensures regulatory compliance
• Improves product quality and safety
• Builds data integrity and trust
• Enables audit readiness
• Protects the company’s reputation

Conclusion

Good Documentation Practice (GDP) is the foundation of pharmaceutical quality systems. It ensures compliance, traceability, data integrity, and patient safety. By implementing robust GDP principles, organisations can enhance operational efficiency, pass regulatory inspections, and foster a strong culture of quality and transparency.

Related:

• Key Differences Between SOP and STP
• Monograph And Standard Test Procedure (STP)
• Method Development and Validation | Key Differences
• Pharmaceutical Analysis in QC and ADL | Complete Guide to QMS, Calibration, Documentation, Troubleshooting & Analytical Techniques (HPLC, GC, MS, NMR, XRD, TLC, Titration, Spectroscopy
• Relative Response Factor (RRF) in Pharmaceutical Analysis
• How To Control Impurities In Pharmaceuticals: Get Mastery In 11 Minutes
• How To Calculate Potency, Purity and Assay In Pharmaceuticals
• Regulatory Affairs

Frequently Asked Questions: GDP

Abbreviations

• EDMS: Electronic document management systems
• SOP: Standard operating procedure
• GDO: Good documentation practice
• GLP: Good laboratory practices

References

• https://www.gmp-compliance.org/gmp-news/final-who-guidance-document-on-good-data-and-record-management-practices
• Indian pharmacopeia
• https://www.usp.org/events-training/course/good-documentation-practices-gdp-and-usp-nf-general-chapter-1029-demand#:~:text=Good%20Documentation%20Practices%20(GDP)%20is,a%20fully%20developed%20quality%20system.